The novel role of DUSP4 in suppressing ferroptosis and promoting cytotoxicity of CD8+ T cells in MSI colorectal cancer

  • 0Department of General Surgery, Colorectal Institute of Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.

|

|

Summary

This summary is machine-generated.

Dual specificity phosphatase 4 (DUSP4) suppresses ferroptosis and enhances CD8+ T cell infiltration in microsatellite instable colorectal cancer (MSI CRC). This finding offers new therapeutic strategies for MSI CRC by targeting DUSP4 to improve immunotherapy effectiveness.

Area Of Science

  • Oncology
  • Immunology
  • Cell Biology

Background

  • Microsatellite instable (MSI) colorectal cancer (CRC) exhibits unique characteristics compared to microsatellite stable (MSS) CRC.
  • The role of ferroptosis in MSI CRC development is suspected but not fully understood.

Purpose Of The Study

  • To investigate the mechanisms by which ferroptosis influences MSI CRC.
  • To explore the regulatory role of Dual Specificity Phosphatase 4 (DUSP4) in ferroptosis and CD8+ T cell infiltration within MSI CRC.

Main Methods

  • Ferroptosis assessment using lipid peroxidation, malondialdehyde, 4-hydroxy-2-nonenal, and intracellular Fe2+ detection.
  • Phosphoproteomic analysis, cytokine array, and flow cytometry to study CD8+ T cell infiltration regulation.
  • Analysis of DUSP4, transferrin receptor (TFRC), c-MYC, cyclin-dependent kinase 7 (CDK7), and C-X-C Motif chemokine ligand 16 (CXCL16) expression and interactions.

Main Results

  • DUSP4 was found to suppress ferroptosis in MSI CRC cells by reducing lipid peroxidation and intracellular Fe2+ accumulation.
  • DUSP4 downregulated TFRC expression, which is transcriptionally regulated by c-MYC.
  • DUSP4 dephosphorylated CDK7, promoting CXCL16 expression and increasing CD8+ T cell infiltration.
  • A positive correlation between CD8+ T cell infiltration and DUSP4 expression in CRC tissues was observed.

Conclusions

  • DUSP4 functions as a negative regulator of ferroptosis in MSI CRC.
  • DUSP4 acts as a positive regulator of CD8+ T cell infiltration in MSI CRC.
  • Targeting DUSP4 and CDK7 may enhance the efficacy of immunotherapy in MSI CRC.